Few studies have examined the impact of endometrial cancer risk factors, such as obesity, diabetes, and nonuse of aspirin on the insulin/IGF and sex hormone axes in normal endometrial tissues. Here, IGF1 is linked to obesity due to melanocortin 4 receptor deficiency.